Inventor · disambiguated record
Robert Jason Herr
Also filed as: HERR ROBERT J · HERR ROBERT JASON
24 granted patents·8 pending applications·61 citations·filing 2004–2023
94Inventor score
Top patents by PatentIndex Score
32 records- 0197US11498940B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2020·Granted Nov 15, 2022·8 cites·30 claims
- 0291US12291535B2Benzodiazepine derivatives, compositions, and methods for treating cognitive impairmentAGENEBIO INC·Filed 2022·Granted May 6, 2025·2 cites·37 claims
- 0385US11225487B27-membered aza-heterocyclic containing δ-opioid receptor modulating compounds, methods of using and making the sameTREVENA INC·Filed 2018·Granted Jan 18, 2022·3 cites·17 claims
- 0485US10246436B26-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the sameTREVENA INC·Filed 2016·Granted Apr 2, 2019·5 cites·18 claims
- 0585US9440982B2Substituted prolines/piperidines as orexin receptor antagonistsEOLAS THERAPEUTICS INC·Filed 2014·Granted Sep 13, 2016·5 cites·26 claims
- 0683US11465980B26-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the sameTREVENA INC·Filed 2019·Granted Oct 11, 2022·2 cites·16 claims
- 0783US9896452B2Substituted prolines/piperidines as orexin receptor antagonistsEOLAS THERAPEUTICS INC·Filed 2016·Granted Feb 20, 2018·5 cites·23 claims
- 0883US9499517B2Substituted prolines / piperidines as orexin receptor antagonistsEOLAS THERAPEUTICS INC·Filed 2014·Granted Nov 22, 2016·7 cites·12 claims
- 0978US7947841B2Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptideEMISPHERE TECH INC·Filed 2008·Granted May 24, 2011·2 cites·15 claims
- 1078US7662771B2Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptideEMISPHERE TECH INC·Filed 2004·Granted Feb 16, 2010·7 cites·10 claims
- 1176US12071453B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2022·Granted Aug 27, 2024·0 cites·33 claims
- 1273US11702408B25-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the sameTREVENA INC·Filed 2018·Granted Jul 18, 2023·1 cites·14 claims
- 1373US2023203002A16-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the sameTREVENA INC·Filed 2022·Application pending·0 cites
- 1469US7544707B2Bicyclic derivatives as PPAR modulatorsLILLY CO ELI·Filed 2004·Granted Jun 9, 2009·6 cites·19 claims
- 1568US8546581B2Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (Glp)-1 compound or a melanocortin-4 receptor (Mc4) agonist peptideJUNGHEIM LOUIS NICKOLAUS·Filed 2011·Granted Oct 1, 2013·1 cites·13 claims
- 1667US8765796B2Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptideEMISPHERE TECH INC·Filed 2013·Granted Jul 1, 2014·0 cites·12 claims
- 1767US8552039B2Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptideHERR ROBERT JASON·Filed 2009·Granted Oct 8, 2013·1 cites·14 claims
- 1865US11912713B27-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the sameTREVENA INC·Filed 2021·Granted Feb 27, 2024·0 cites·17 claims
- 1965US7749992B2Compounds and methods for treating dislipidemiaLILLY CO ELI·Filed 2004·Granted Jul 6, 2010·3 cites·14 claims
- 2063US8889683B2Substituted quinoxalines as inhibitors of fatty acid binding proteinCHENG CLIFFORD·Filed 2011·Granted Nov 18, 2014·2 cites·9 claims
- 2163US8232274B2Pyridazinone derivatives useful as glucan synthase inhibitorsTING PAULINE C·Filed 2008·Granted Jul 31, 2012·1 cites·20 claims
- 2262US2023303531A15-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the sameTREVENA INC·Filed 2023·Application pending·0 cites
- 2361US11117884B2Potent gamma-secretase modulatorsMASSACHUSETTS GEN HOSPITAL·Filed 2019·Granted Sep 14, 2021·0 cites·14 claims
- 2460US11414425B2Benzodiazepine derivatives, compositions, and methods for treating cognitive impairmentAGENEBIO INC·Filed 2019·Granted Aug 16, 2022·0 cites·51 claims
- 2558US2016229887A1Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2657US2024336642A1Inhibitors of 12/15-lipoxygenaseMASSACHUSETTS GEN HOSPITAL·Filed 2022·Application pending·0 cites
- 2755US2007293423A1Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist PeptideLILLY CO ELI·Filed 2004·Application pending·0 cites
- 2851US2023098667A1Benzodiazepine derivatives, compositions, and methods for treating cognitive impairmentAGENEBIO INC·Filed 2020·Application pending·0 cites
- 2940US2010204207A1Compounds and Methods for Treating DyslipidemiaCHEN XINCHAO·Filed 2010·Application pending·0 cites
- 3037US10597401B2Methods and intermediates for the preparation of omacetaxine and cephalotaxine derivatives thereofALBANY MOLECULAR RES INC·Filed 2016·Granted Mar 24, 2020·0 cites·22 claims
- 3135US10472346B2Potent gamma-secretase modulatorsTHE GENERAL HOSPITAL COPORATION·Filed 2015·Granted Nov 12, 2019·0 cites·18 claims
- 3230US2011312995A1Bridged and fused heterocyclic antidiabetic compoundsJOSIEN HUBERT B·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →